Sirnaomics
North America, Maryland, United States, Gaithersburg
Description
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Investor Profile
Sirnaomics has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 50% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Corporate Round rounds (top funding stages).
- Majority of deals are located in United States, China.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
Stage Focus
- Series B (25%)
- Series A (25%)
- Corporate Round (25%)
- Seed (25%)
Country Focus
- United States (75%)
- China (25%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Genetics
- Medical
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
